thyssenkrupp nucera AG & Co KgaA
XETRA:NCH2
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.885
18.86
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one NCH2 stock under the Base Case scenario is 14.56 EUR. Compared to the current market price of 8.36 EUR, thyssenkrupp nucera AG & Co KgaA is Undervalued by 43%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
thyssenkrupp nucera AG & Co KgaA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for NCH2 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
thyssenkrupp nucera AG & Co KgaA
Balance Sheet Decomposition
thyssenkrupp nucera AG & Co KgaA
Current Assets | 1.1B |
Cash & Short-Term Investments | 702.2m |
Receivables | 188.2m |
Other Current Assets | 231.4m |
Non-Current Assets | 90.2m |
Long-Term Investments | 300k |
PP&E | 12.5m |
Intangibles | 56.2m |
Other Non-Current Assets | 21.2m |
Current Liabilities | 448.1m |
Accounts Payable | 157.4m |
Accrued Liabilities | 4.5m |
Other Current Liabilities | 286.2m |
Non-Current Liabilities | 23.9m |
Long-Term Debt | 3.3m |
Other Non-Current Liabilities | 20.6m |
Earnings Waterfall
thyssenkrupp nucera AG & Co KgaA
Revenue
|
958.8m
EUR
|
Cost of Revenue
|
-848.2m
EUR
|
Gross Profit
|
110.6m
EUR
|
Operating Expenses
|
-110.9m
EUR
|
Operating Income
|
-313k
EUR
|
Other Expenses
|
12.2m
EUR
|
Net Income
|
11.9m
EUR
|
Free Cash Flow Analysis
thyssenkrupp nucera AG & Co KgaA
EUR | |
Free Cash Flow | EUR |
thyssenkrupp nucera reported its highest ever quarterly sales at EUR 236 million in Q3, driven by growth in Chlor-Alkali and AWE orders. A significant milestone was a 20% sales increase in the AWE sector, notably with their NEOM project. However, EBIT declined to EUR 1 million, impacted by lower margins and higher R&D and operational costs. The company maintains its sales guidance for FY '23-'24 at EUR 820-900 million but remains cautious regarding FY '24-'25 due to market uncertainties in green hydrogen. CEO Werner Ponikwar emphasized continued R&D and project execution to navigate short-term challenges and capitalize on long-term growth opportunities.
What is Earnings Call?
NCH2 Profitability Score
Profitability Due Diligence
thyssenkrupp nucera AG & Co KgaA's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
thyssenkrupp nucera AG & Co KgaA's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
NCH2 Solvency Score
Solvency Due Diligence
thyssenkrupp nucera AG & Co KgaA's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Score
thyssenkrupp nucera AG & Co KgaA's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NCH2 Price Targets Summary
thyssenkrupp nucera AG & Co KgaA
According to Wall Street analysts, the average 1-year price target for NCH2 is 15.67 EUR with a low forecast of 8.59 EUR and a high forecast of 26.78 EUR.
Dividends
Current shareholder yield for NCH2 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
NCH2 Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
thyssenkrupp nucera AG & Co KgaA is a DE-based company operating in Construction & Engineering industry. The company is headquartered in Dortmund, Nordrhein-Westfalen and currently employs 508 full-time employees. The company went IPO on 2023-07-07. thyssenkrupp nucera AG & Co. KGaA, formerly Thyssenkrupp Uhde Chlorine Engineers Gmbh, is a Germany-based company, which operates as an electrolysis technology provider. The firm's business consists of the design, engineering and procurement of electrolysis technologies and the plants into which they are incorporated, as well as the provision of aftermarket services for existing plants. The firm provides green hydrogen solutions, Chlor-alkali solutions, and hydrochloric acid solutions.
Contact
IPO
Employees
Officers
The intrinsic value of one NCH2 stock under the Base Case scenario is 14.56 EUR.
Compared to the current market price of 8.36 EUR, thyssenkrupp nucera AG & Co KgaA is Undervalued by 43%.